Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

被引：0
|
作者：
M. Opdam
V. van der Noort
M. Kleijn
A. Glas
I. Mandjes
S. Kleiterp
F. S. Hilbers
D. T. Kruger
A. D. Bins
P. C. de Jong
P. P. J. B. M. Schiphorst
T. van Dalen
B. Flameling
R. C. Rietbroek
A. Beeker
S. M. van den Heiligenberg
S. D. Bakker
A. N. M. Wymenga
I. M. Oving
R. M. Bijlsma
P. J. van Diest
J. B. Vermorken
H. van Tinteren
S. C. Linn
机构：
[1] Netherlands Cancer Institute,Department of Molecular Pathology
[2] Netherlands Cancer Institute,Biometrics Department
[3] Agendia NV,Medical Affairs
[4] Amsterdam UMC,Department of Medical Oncology
[5] Sint-Antonius Hospital,Department of Medical Oncology
[6] Streekziekenhuis Koningin. Beatrix,Department of Internal Medicine
[7] Diakonessenhuis,Department of Surgery
[8] OLVG,Department of Medical Oncology
[9] Red Cross Hospital,Department of Internal Medicine
[10] Spaarne Gasthuis,Department of Medical Oncology
[11] Dijklander Ziekenhuis,Department of Medical Oncology
[12] Zaans Medisch Centrum,Department of Internal Medicine
[13] Medisch Spectrum Twente,Department of Medical Oncology
[14] Ziekenhuisgroep Twente,Department of Medical Oncology
[15] UMCU,Department of Medical Oncology
[16] UMCU,Department of Pathology
[17] University Hospital Antwerp (UZA),Department of Medical Oncology
[18] University of Antwerp,Faculty of Medicine and Health Sciences
[19] Trial and Data Center,Department of Medical Oncology
[20] Princess Maxima Centre for Pediatric Oncology,undefined
[21] Netherlands Cancer Institute,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 194卷
关键词：
Early breast cancer; Postmenopausal; MammaPrint 70-gene signature; Prognosis; Endocrine treatment; Overtreatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 278
页数：13
相关论文
共 50 条
  • [21] Impact of the 70-Gene Signature on Chemotherapy Administration in Dutch Early Stage Breast Cancer Patients
    van Steenhoven, J.
    Kuijer, A.
    Schreuder, K.
    van Bommel, A.
    Elias, S.
    Smorenburg, C.
    Linn, S.
    Rutgers, E.
    Siesling, S.
    van Dalen, T.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S54 - S55
  • [22] Long-term impact of the 70-gene signature on breast cancer outcome
    Drukker, C. A.
    van Tinteren, H.
    Schmidt, M. K.
    Rutgers, E. J. Th.
    Bernards, R.
    van de Vijver, M. J.
    van't Veer, L. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 143 (03) : 587 - 592
  • [23] Validation of 70-gene prognosis signature in node-negative breast cancer
    J. M. Bueno-de-Mesquita
    S. C. Linn
    R. Keijzer
    J. Wesseling
    D. S. A. Nuyten
    C. van Krimpen
    C. Meijers
    P. W. de Graaf
    M. M. E. M. Bos
    A. A. M. Hart
    E. J. T. Rutgers
    J. L. Peterse
    H. Halfwerk
    R. de Groot
    A. Pronk
    A. N. Floore
    A. M. Glas
    L. J. van’t Veer
    M. J. van de Vijver
    Breast Cancer Research and Treatment, 2009, 117 : 483 - 495
  • [24] The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
    Knauer, Michael
    Mook, Stella
    Rutgers, Emiel J. T.
    Bender, Richard A.
    Hauptmann, Michael
    van de Vijver, Marc J.
    Koornstra, Rutger H. T.
    Bueno-de-Mesquita, Jolien M.
    Linn, Sabine C.
    van't Veer, Laura J.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (03) : 655 - 661
  • [25] Validation of 70-gene prognosis signature in node-negative breast cancer
    Bueno-de-Mesquita, J. M.
    Linn, S. C.
    Keijzer, R.
    Wesseling, J.
    Nuyten, D. S. A.
    van Krimpen, C.
    Meijers, C.
    de Graaf, P. W.
    Bos, M. M. E. M.
    Hart, A. A. M.
    Rutgers, E. J. T.
    Peterse, J. L.
    Halfwerk, H.
    de Groot, R.
    Pronk, A.
    Floore, A. N.
    Glas, A. M.
    van't Veer, L. J.
    van de Vijver, M. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (03) : 483 - 495
  • [26] Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer
    J. M. N. Lopes Cardozo
    M. K. Schmidt
    L. J. van ’t Veer
    F. Cardoso
    C. Poncet
    E. J. T. Rutgers
    C. A. Drukker
    Breast Cancer Research and Treatment, 2021, 189 : 399 - 410
  • [27] Is 70-gene prognostic signature in breast cancer for Korean different from European?
    Na, K. Y.
    Kim, K. S.
    Park, J. M.
    Kim, J. Y.
    Kim, M. S.
    Lee, J. E.
    Kim, H. J.
    Moon, B. I.
    Kwak, K.
    Park, K.
    EJC SUPPLEMENTS, 2010, 8 (03): : 102 - 102
  • [28] Analysis of the 70-gene breast cancer prognosis signature in a general hospital population
    Wittner, Ben S.
    Sgroi, Dennis C.
    Ryan, Paula D.
    Bruinsma, Tako J.
    Glas, Annuska M.
    Male, Anitha
    Dahiya, Sonika
    Habin, Karleen
    Bernards, Rene
    Haber, Daniel A.
    van 'tVeer, Laura J.
    Ramaswamy, Sridhar
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3489S - 3489S
  • [29] The 70-gene MammaPrint® signature predicts response to neoadjuvant chemotherapy in breast cancer
    Strayer, Marieke
    Glass, Annuska
    Hannemann, Juliane
    Wesseling, Jelle
    de Vijver, Marc van
    Rutgers, Emiel
    Peeters, Marie-Jeanne Vrancken
    van Tinteren, Harm
    Veer, Laura van 't
    Rodenhuis, Sjoerd
    CANCER RESEARCH, 2009, 69
  • [30] Long-term impact of the 70-gene signature on breast cancer outcome
    C. A. Drukker
    H. van Tinteren
    M. K. Schmidt
    E. J. Th. Rutgers
    R. Bernards
    M. J. van de Vijver
    L. J. van’t Veer
    Breast Cancer Research and Treatment, 2014, 143 : 587 - 592
12345